Featured Articles

  1. Cross-Border M&A: 10 Key Trends To Watch In 2023 4/17/2023

    Many observers believe deal volume will remain buoyant throughout 2023. The need for access to cash is expected to continue to drive M&A decision-making. Heightened regulatory scrutiny, supply chain weakness, and consolidation are a few of the trends to watch for the remainder of the year.

  2. The State Of Global Clinical Trial Disclosure 4/17/2023

    See what industry organizations are saying about trial transparency, regulations by region, what penalties are on the books, and whether they are enforced.

  3. Pharma R&D Annual Review 2023 4/17/2023

    Although COVID-19 has not quite finished its final act, it appears the industry is emerging from this tumultuous episode stronger and emboldened. Find out if the 2023 pipeline was a page-turner in this literary-themed Pharmaprojects’ 2023 review of trends in pharmaceutical R&D.

  4. 'Pivotal Time For CROs': ICON CEO Cutler On Changing APAC Trial Trends 3/23/2023

    The CEO of one of the global top five CROs recently pointed out an opportunity in decentralized trials that might be a “game changer” in the pharma industry over the next five years. He also refers to the need to accept new technologies by both clinical trial sites and regulators.

  5. Cardio Conversations: PFA, Electrophysiology, And What It Takes To Be A Physician Inventor 3/23/2023

    Co-Founder of Farapulse and Field Medical Steven Mickelsen and Medtech Insight Editor Reed Miller discuss pulsed field ablation, an emerging technology that is changing electrophysiology.

  6. Unlocking The Potential Of Decentralized Clinical Trials 3/23/2023

    Explore the current DCT landscape and its evolution, as well as the key advantages of incorporating decentralized attributes and how barriers to their inclusion can be overcome.

  7. Cardio Conversations: PFA Electrophysiology And What It Takes To Be a Physician Inventor 2/15/2023

    Hear from Steven Mickelsen, a pioneer in pulsed field ablation (PFA), as he delves into how PFA is set to change the electrophysiology market as well as his experiences as a physician-entrepreneur. 

  8. US FDA May Become More Insistent On Accelerated Approval Confirmatory Trials Timing 2/15/2023

    Learn how review divisions may take a tougher line with sponsors on the design and timing of studies to verify clinical benefit.

  9. The Stories And Statistics Behind Breast Cancer: Part Two 2/15/2023

    In part two of a survivor series, several individuals who beat breast cancer, and their loved ones, discuss the challenges and treatments they underwent while fighting the disease.

  10. The Stories And Statistics Behind Breast Cancer: Part One 2/15/2023

    As told by survivors of breast cancer and their loved ones, learn about the treatments, and challenges they all faced while battling the disease.